Capecitabine (and 5 fluorouracil) cardiotoxicity. Metabolic considerations
- PMID: 21726348
- DOI: 10.1111/j.1524-4741.2011.01120.x
Capecitabine (and 5 fluorouracil) cardiotoxicity. Metabolic considerations
Comment on
-
Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.Breast J. 2010 Sep-Oct;16 Suppl 1:S45-8. doi: 10.1111/j.1524-4741.2010.01004.x. Breast J. 2010. PMID: 21050310